[Federal Register: June 3, 2004 (Volume 69, Number 107)]
[Notices]
[Page 31411-31412]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr03jn04-87]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated February 4, 2004, and published in the Federal
Register on February 18, 2004, (69 FR 7655), Cambrex Charles City,
Inc., 1205 11th Street, Charles City, Iowa 50619, made application by
renewal to the Drug
[[Page 31412]]
Enforcement Administration (DEA) for registration as a bulk
manufacturer of the basic classes of controlled substances listed
below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Amphetamaine (1100)........................ II
Methylphenidate (1724)..................... II
Dextropropoxyphene (9273).................. II
------------------------------------------------------------------------
The firm plans to manufacture bulk controlled substances for
distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in Title 21, United States Code, section 823(a) and
determined that the registration of Cambrex Charles City, Inc. to
manufacture the listed controlled substances is consistent with the
public interest at this time. DEA has investigated Cambrex Charles
City, Inc. to ensure that the company's registration is consistent with
the public interest. This investigation has included inspection and
testing of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to 21 U.S.C. 823
and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office
of Diversion Control, hereby orders that the application submitted by
the above firm for registration as a bulk manufacturer of the basis
classes of controlled substances listed as granted.
Dated: May 21, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 04-12456 Filed 6-2-04; 8:45 am]
BILLING CODE 4410-09-M